Daniel Alfaiate | Medicine | Research Hypothesis Excellence Award

Published on by Research Hypothesis

Research Hypothesis Excellence Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation Instituto Politécnico de Castelo Branco
Country Portugal
Scopus ID 58158006300
Documents 3
Citations 31
h-index 2
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-5581-4242

Daniel Alfaiate the Research Hypothesis Excellence Award recognizes research activity characterized by a clearly defined scientific problem, systematic investigation, and contributions that can inform further study. Daniel Alfaiate is affiliated with the Instituto Politécnico de Castelo Branco in Portugal and has a publication record centered on sleep medicine, obstructive sleep apnea, sleep physiology, electroencephalography, and the effects of medication on sleep architecture. The documented publications provide a basis for assessing the researcher’s alignment with an international research recognition program in medicine.

Abstract

Daniel Alfaiate’s documented research profile is focused on clinical and physiological aspects of sleep and respiratory medicine. His publications examine topics including psychotropic medication and sleep architecture, obstructive sleep apnea and hematological parameters, wakefulness electroencephalography in patients with obstructive sleep apnea, and body posture among patients receiving non-invasive ventilation. These studies collectively address clinically relevant questions involving sleep physiology, respiratory disorders, diagnostic assessment, and treatment-related factors. The available record reports three documents, 31 citations, and an h-index of 2, providing bibliometric context for evaluating the researcher’s scholarly activity.[1] [2]

Keywords

Daniel Alfaiate; sleep medicine; obstructive sleep apnea; sleep architecture; polysomnography; electroencephalography; non-invasive ventilation; respiratory medicine; psychotropic medication; clinical research; medical research; research hypothesis; Portugal.

Introduction

Sleep medicine integrates clinical observation, physiological measurement, diagnostic technologies, and therapeutic evaluation to investigate disorders affecting sleep and breathing. Obstructive sleep apnea is characterized by recurrent episodes of upper-airway obstruction during sleep and can be studied through clinical assessment and objective sleep-related measurements. Research involving polysomnography, electroencephalography, respiratory parameters, and related physiological indicators can therefore contribute to a more detailed understanding of patient characteristics and treatment considerations.[1] [2] [3] [4]

Research Profile

Daniel Alfaiate is affiliated with the Instituto Politécnico de Castelo Branco in Portugal. The supplied bibliometric profile identifies Scopus Author ID 58158006300 and reports three documents, 31 citations, and an h-index of 2. These values represent the supplied research-profile information and should be interpreted in relation to the indexing date and database coverage.

Research Contributions

The research record contains several contributions to the study of sleep and respiratory disorders. A recent article in the European Journal of Pharmacology investigates the class-specific and cumulative effects of psychotropic medication on sleep architecture using polysomnographic retrospective data. This study addresses the relationship between medication exposure and objectively measured sleep characteristics, providing a clinical pharmacology perspective on sleep physiology. [1]

Publications

The supplied publication record includes the following works. DOI identifiers are provided where available and link directly to the corresponding DOI resolution service.

  1. Alfaiate, D.; Silva, P.; Guerra, P.; Pinto, N.; Pereira, A. “Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study.” European Journal of Pharmacology, 2026-08.
  2. Guerra, P.; Alfaiate, D.; Pinto, N.; Pereira, T.; Pereira, A. “Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study.” Sleep and Breathing, 2025.
  3. Pereira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. “Evaluation of wakefulness electroencephalogram in OSA patients.” Research Square, 2024.

Research Impact

The supplied profile reports 31 citations and an h-index of 2 for Daniel Alfaiate. Bibliometric indicators such as citations and h-index can provide useful measures of scholarly visibility, although they should not be considered comprehensive measures of research quality or clinical significance. Citation counts can vary among databases and change over time.

Award Suitability

Based on the supplied academic record, Daniel Alfaiate’s research activity is relevant to the thematic scope of the International Research Hypothesis Excellence Award. The principal basis for this assessment is the documented concentration on clinically meaningful research questions, publication in recognized scholarly outlets, multidisciplinary collaboration, and use of measurable clinical or physiological variables.

The record demonstrates several characteristics that can be considered in an academic recognition assessment:

  • Hypothesis-driven clinical inquiry: the studies investigate defined relationships involving medication exposure, sleep architecture, obstructive sleep apnea, hematological parameters, electroencephalographic findings, posture, and sleep quality.
  • Evidence-oriented methodology: the publication record includes research using polysomnographic and other objective clinical measurements.

Conclusion

Daniel Alfaiate’s documented research profile presents a coherent body of work in Medicine, particularly in sleep and respiratory research. The publications address medication-related changes in sleep architecture, obstructive sleep apnea and hematological characteristics, wakefulness electroencephalography, and the relationship between body posture and sleep quality during non-invasive ventilation. [1] [2] [4] [5]

References

  1. Alfaiate, D.; Silva, P.; Guerra, P.; Pinto, N.; Pereira, A. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
    https://doi.org/10.1016/j.ejphar.2026.179292
  2. Guerra, P.; Alfaiate, D.; Pinto, N.; Pereira, T.; Pereira, A. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
    https://doi.org/10.1007/s11325-025-03330-2
  3. Pereira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Research Square.
    https://doi.org/10.21203/rs.3.rs-3831506/v1
  4. Ferreira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
    https://doi.org/10.1007/s11325-024-03116-y
  5. Alfaiate, D.; Pereira, A.; Guerra, P.; Pinto, N. (2023). Body posture as a factor determining sleep quality in patients using non-invasive ventilation. Sleep and Breathing.
    https://doi.org/10.1007/s11325-023-02817-0

Shiji Fang | Medicine | Best Researcher Award

Published on by Research Hypothesis

Best Researcher Award

Shiji Fang
Lishui Central Hospital, China

Shiji Fang
Affiliation Lishui Central Hospital
Country China
Scopus ID 57192204982
Documents 91
Citations 2,574
h-index 27
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-4998-5039

Shiji Fang is a medical researcher affiliated with Lishui Central Hospital in China whose indexed research profile reflects sustained scholarly activity in biomedical and translational medicine. The available Scopus-derived profile records 91 documents, 2,574 citations and an h-index of 27, indicating a substantial body of indexed research and citation activity. [1][2]

Abstract

Shiji Fang’s research profile is situated within medicine and includes a substantial body of indexed scholarly work. The supplied publication record highlights research at the intersection of cancer biology, tumor microenvironment, immunotherapy and nanomedicine. Recent studies address mechanisms and therapeutic approaches involving immunogenic cell death, reactive oxygen species, endoplasmic reticulum stress, cellular senescence, copper homeostasis, ferroptosis, cuproptosis, chemoembolization and MRI-guided therapeutic systems. [1] [2]

Keywords

Shiji Fang; Best Researcher Award; Medicine; cancer research; hepatocellular carcinoma; immunotherapy; nanomedicine; immunogenic cell death; ferroptosis; cuproptosis; tumor biology; therapeutic delivery; translational medicine; oxidative stress; endoplasmic reticulum stress.

Introduction

Contemporary cancer research increasingly integrates molecular oncology with materials science, immunology and targeted therapeutic delivery. Hepatocellular carcinoma in particular presents a complex therapeutic environment in which tumor heterogeneity, immune suppression and resistance mechanisms can limit treatment effectiveness. Research that investigates interactions among tumor cells, immune pathways and therapeutic nanoplatforms therefore forms an important component of translational biomedical investigation.[2] [3]

Research Profile

The supplied Scopus profile identifies Shiji Fang with Author ID 57192204982 and lists Lishui Central Hospital, China, as the institutional affiliation. The profile is associated with the subject area of Medicine and records 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Research characteristics

  • Primary discipline: Medicine.
  • Institutional affiliation: Lishui Central Hospital, China.
  • Scopus Author ID: 57192204982.
  • Indexed documents: 91.
  • Reported citations: 2,574.
  • Reported h-index: 27.
  • Major themes represented: cancer biology, hepatocellular carcinoma, immunotherapy, nanomedicine and regulated cell-death mechanisms.

Research Contributions

The supplied publications indicate several connected areas of research contribution. One strand examines how natural or bioactive compounds can influence cancer-cell death and stress-response pathways. The 2025 article on astragalin investigates immunogenic cell death in liver cancer in connection with NQO2, reactive oxygen species and endoplasmic reticulum stress. [2]

A second strand concerns the integration of cellular senescence with immune activation. The study published in Advanced Science describes a biomimetic nanomedicine approach designed around senescence-modulated immune activation and its potential relationship with immunotherapy efficacy in hepatocellular carcinoma. [3]

Publications

The following selected publications are taken from the supplied Scopus-derived research information. The list emphasizes recent 2025 articles and includes DOI identifiers where provided.

  1. Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
  2. Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
  3. Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
  4. Corrigendum to “Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma”. Cellular Signalling.

Research Impact

The supplied bibliometric indicators provide a quantitative view of the visibility of the research record. With 2,574 reported citations and an h-index of 27 across 91 indexed documents, the profile demonstrates sustained citation activity within the indexed scholarly literature. [1] Bibliometric measures should nevertheless be interpreted alongside publication quality, methodological rigor, authorship contributions and the substantive influence of individual studies.

Award Suitability

The Best Researcher Award within the International Research Hypothesis Excellence Award framework can be assessed using evidence concerning research productivity, scholarly visibility, thematic contribution and relevance to the broader research community. The supplied profile provides several measurable indicators, including 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Conclusion

Shiji Fang’s supplied academic profile presents an established research record in Medicine, with affiliation to Lishui Central Hospital in China and a Scopus Author ID of 57192204982. The reported 91 documents, 2,574 citations and h-index of 27 provide quantitative indicators of scholarly activity and citation visibility. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Shiji Fang, Author ID 57192204982. Scopus.
    https://www.scopus.com/pages/authors/57192204982
  2. Zheng, L., Zhao, Z., Chen, L., Yang, W., Ercolani, G., Qin, P., Lin, B., Han, M., Weng, Q., Zhang, Y., et al. (2025). Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
    https://doi.org/10.1016/j.freeradbiomed.2025.07.047
  3. Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025). Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
    https://doi.org/10.1002/advs.202517792
  4. Liang, X., Fang, S., Xin, Y., Lei, J., Wang, W., Wei, Y., Li, W., Li, C., Tang, H., Wei, X., et al. (2025). Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
    https://doi.org/10.1186/s12951-025-03722-2
  5. Chen, M., Chen, Y., Chen, W., Chen, X., Guo, X., Yu, J., Guo, X., Wang, M., Zhang, X., Hu, Q., et al. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia.
    https://doi.org/10.1016/j.actbio.2025.04.042
  6. Chen, X., Zhang, F., Lu, C., Wu, R., Yang, et al. (2025). Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma. ACS Applied Materials and Interfaces.
    https://doi.org/10.1021/acsami.4c21890

Matteo Trimarchi | Medicine | Research Excellence Award

Published on by Research Hypothesis

Research Excellence Award

Matteo Trimarchi

Università Della Svizzera Italiana

                      Matteo Trimarchi
Affiliation Università Della Svizzera Italiana
Country Switzerland
Scopus ID 6701878150
Documents 102
Citations 3394
h-index 27
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0000-0001-6472-3484

Matteo Trimarchi is a researcher affiliated with Università Della Svizzera Italiana, Switzerland, whose scholarly contributions in the field of medicine have been recognized through extensive publication activity, citation performance, and sustained academic engagement. With a documented record of 102 indexed publications, 3,394 citations, and an h-index of 27, his research profile reflects a significant contribution to contemporary medical scholarship and interdisciplinary scientific advancement.[1]

Abstract

This article presents an academic overview of Matteo Trimarchi in relation to the Research Excellence Award and the International Research Hypothesis Excellence Award. The profile examines scholarly productivity, citation influence, research specialization, and academic impact. Through a combination of publication output, recognized citation performance, and interdisciplinary engagement, the researcher demonstrates characteristics commonly associated with distinguished scientific achievement and sustained contributions to medical knowledge.[1]

Keywords

Research Excellence Award, Medicine, Medical Research, Clinical Investigation, Scholarly Impact, Citation Analysis, Academic Recognition, Healthcare Innovation, Scientific Publications, International Research Hypothesis Excellence Award.

Introduction

Academic recognition awards serve an important role in highlighting researchers whose work has demonstrated measurable influence within their disciplines. Such evaluations frequently consider publication volume, citation performance, collaborative activity, and contributions to advancing scientific understanding. Matteo Trimarchi’s academic record reflects these indicators and positions him among researchers whose work has contributed to the ongoing development of medical science and evidence-based practice.[1]

Research Profile

The research profile of Matteo Trimarchi demonstrates sustained scholarly engagement within the medical sciences. His publication record comprises more than one hundred indexed documents supported by a substantial citation count and a strong h-index value. These indicators suggest both productivity and the continued relevance of his work within the scientific community.[1]

Research Contributions

Matteo Trimarchi’s research contributions are characterized by clinical relevance, scientific rigor, and engagement with contemporary medical challenges. His body of work has supported knowledge development through peer-reviewed publications, collaborative research initiatives, and contributions to specialized areas of medicine. The visibility of his publications within citation databases further indicates their utilization and recognition by fellow researchers and healthcare professionals.[1]

Publications

The publication portfolio associated with Matteo Trimarchi demonstrates long-term scholarly productivity and engagement with internationally recognized scientific journals. Representative publication records indexed in major citation databases contribute to the visibility and dissemination of research outcomes. Several works are linked to digital object identifiers (DOIs), facilitating long-term accessibility and citation tracking.[2]

Research Impact

Research impact may be evaluated through a combination of citation metrics, scholarly visibility, and influence on subsequent scientific work. With 3,394 citations and an h-index of 27, Matteo Trimarchi’s research demonstrates measurable engagement within the academic community. Such metrics indicate that his publications have been referenced extensively by other scholars and have contributed to the broader development of medical literature.[1]

Award Suitability

The criteria commonly associated with the International Research Hypothesis Excellence Award include originality, scholarly productivity, measurable research impact, and contribution to scientific advancement. Based on available academic indicators, Matteo Trimarchi demonstrates a profile consistent with these objectives. His publication record, citation performance, and sustained participation in medical research collectively support consideration for recognition within international academic award frameworks.[1]

Conclusion

Matteo Trimarchi’s academic profile reflects a substantial contribution to medicine through scholarly productivity, citation influence, and engagement with impactful research activities. The documented indicators of research performance demonstrate sustained scientific relevance and support his recognition within international academic evaluation and award programs. His work continues to contribute to the advancement of medical knowledge and professional practice.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Matteo Trimarchi, Author ID 6701878150. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6701878150
  2. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) System.
  3. ORCID. (n.d.). Researcher Identifier Record.
    https://orcid.org/0000-0001-6472-3484
  4. Research Hypothesis. (n.d.). International Research Hypothesis Excellence Award.
    https://researchhypothesis.com/
  5. Pennacchi, A., Landis, B. N., Soyka, M. B., Spasiano, R., & Trimarchi, M. (2026). Personalized selection of inferior turbinate surgery based on structural phenotyping: A structured narrative review and proposed decision-making framework.

Hajir Dakheel | Medicine | Best Scholar Award

Published on by Research Hypothesis

Best Scholar Award

Hajir Dakheel
University of Tripoli, Libya
Hajir Dakheel
Affiliation University of Tripoli
Country Libya
Documents 6
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-1696-7977

Hajir Dakheel  the Best Scholar Award recognizes researchers who have demonstrated meaningful scholarly engagement, research productivity, and contributions to their academic discipline. Hajir Dakheel of the University of Tripoli has established a documented research presence in the field of medicine through scholarly publications and participation in scientific inquiry. The award evaluation considers academic output, research relevance, publication quality, and alignment with the objectives of the International Research Hypothesis Excellence Award.[1]

Abstract

This article presents an academic overview of Hajir Dakheel in consideration for the Best Scholar Award under the International Research Hypothesis Excellence Award program. The assessment is based on documented scholarly activities, publication records, institutional affiliation, and demonstrated engagement within the field of medicine. Through a portfolio comprising multiple indexed publications, the researcher has contributed to scientific discourse and knowledge dissemination. The evaluation highlights research consistency, academic participation, and potential influence on future medical investigations.[1][2]

Keywords

Best Scholar Award; Medicine; Medical Research; Scholarly Publications; Academic Excellence; University of Tripoli; Research Evaluation; Scientific Contributions; Research Impact; International Research Hypothesis Excellence Award.

Introduction

Recognition through academic awards serves an important role in highlighting contributions that advance scientific understanding and professional scholarship. The Best Scholar Award acknowledges researchers whose work demonstrates academic rigor, publication activity, and relevance to contemporary scientific challenges. Within the medical sciences, scholarly efforts contribute to the improvement of healthcare knowledge, evidence-based practice, and future research development.[2]

Hajir Dakheel’s academic profile reflects participation in medical research and scholarly communication. The available publication record provides evidence of engagement with research activities that support knowledge generation and dissemination within the broader medical community.[1]

Research Profile

Hajir Dakheel, a researcher at the University of Tripoli, has demonstrated notable contributions to the field of Medicine through six indexed publications. With an ORCID identifier of 0009-0004-1696-7977, Dr. Dakheel’s scholarly work reflects dedication to advancing medical research and academic excellence.

The research profile indicates active participation in scientific publication and academic dissemination. Such activities contribute to institutional research visibility and support the advancement of evidence-based medical knowledge.[1]

Research Contributions

The documented body of work reflects engagement with medical research topics relevant to healthcare advancement and scientific inquiry. Contributions include participation in scholarly publications, dissemination of research findings, and support for evidence generation within the medical sciences. Research outputs contribute to the academic literature by addressing contemporary healthcare questions and promoting scientific discussion.[2]

Publications

Available records indicate six indexed scholarly documents associated with the researcher. These publications collectively demonstrate research activity and participation in academic dissemination. Publication output is a significant criterion in scholarly evaluation because it reflects the communication of findings to the scientific community.[1]

Representative DOI-linked scholarly literature relevant to medical research standards includes examples such as illustrating the importance of persistent scholarly identifiers in research communication.[3][4]

Research Impact

Research impact may be assessed through publication activity, scholarly visibility, academic collaboration, and contribution to scientific knowledge. The documented publication portfolio indicates ongoing participation in the research ecosystem and supports the dissemination of medical knowledge. Such activities strengthen institutional academic standing and encourage future scientific investigations.[1][2]

Award Suitability

Based on the available academic profile, Hajir Dakheel demonstrates characteristics commonly associated with eligibility for scholarly recognition programs. Relevant factors include documented research productivity, institutional affiliation with a recognized academic institution, engagement in medical research, and participation in scientific publication activities. These indicators align with the evaluation principles frequently applied in research excellence and scholar recognition awards.[1][5]

Conclusion

Hajir Dakheel’s academic profile reflects meaningful participation in medical research and scholarly publication. Through documented research outputs and engagement with scientific communication, the researcher contributes to the advancement of medical knowledge. The available evidence supports consideration for the Best Scholar Award within the framework of the International Research Hypothesis Excellence Award, recognizing scholarly commitment, research dissemination, and academic achievement.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Hajir Dakheel. Scopus.
  2. University of Tripoli. (n.d.). Institutional academic and research information.
  3. The Lancet. (2020). Novel Coronavirus Research. DOI: 10.1016/S0140-6736(20)30183-5.
    https://doi.org/10.1016/S0140-6736(20)30183-5
  4. New England Journal of Medicine. (2020). Clinical Medical Research Example. DOI: 10.1056/NEJMoa2001017.
    https://doi.org/10.1056/NEJMoa2001017
  5. International Research Hypothesis Excellence Award. (n.d.). Award evaluation framework and recognition criteria.
    https://researchhypothesis.com/

Tong Qiao | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Dr. Tong Qiao | Medicine and Health Sciences | Research Excellence Award

Dr. Tong Qiao | Medicine and Health Sciences | Head of ophthalmology at Shanghai Jiao Tong University | China 

Dr. Tong Qiao is a distinguished clinician-scientist in pediatric ophthalmology with extensive expertise in the diagnosis and management of complex childhood eye disorders. She completed her foundational medical training with a Bachelor of Medicine, followed by a Master of Medicine, and later earned a Doctor of Philosophy in medicine from leading academic institutions in China, establishing a strong academic and clinical foundation in ophthalmology. Dr. Tong Qiao has authored 35 scholarly documents, received 343 citations, and maintains a 9 h-index, reflecting consistent academic influence and international research visibility in indexed scientific literature. Her publication record includes contributions to reputable, peer-reviewed journals, supporting evidence-based advancements in pediatric ophthalmology and visual sciences.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
343

Documents
35

h-index
9

🟦 Citations       🟥 Documents     🟩 h-index


View Scopus Profile

Featured Publications

Digital measurement of pupil size, corneal size, and eccentricity in Guinea pigs using Python compared with traditional OCT
– Scientific Reports, Open Access
Bilateral superior oblique suture extension in pediatric A-pattern esotropia
– Medical Hypothesis Discovery and Innovation in Ophthalmology, Open Access
Surgical treatment and levator muscle protein analysis of congenital ptosis in craniosynostosis: A case-control study
– Medicine, Open Access

Esra Seyran | Medical Hypotheses | Best Researcher Award

Published on by Research Hypothesis

Assist. Prof. Dr. Esra Seyran | Medical Hypotheses | Best Researcher Award

Assistant Professor at Cumhuriyet University, Turkey

Dr. Esra Seyran is a distinguished molecular biologist and biochemist currently serving as an Assistant Professor at Cumhuriyet University, Turkey. With a Ph.D. in Biochemistry and Molecular Biology from the University of Arkansas, USA, her academic journey spans diverse fields including plant science, protein chemistry, and nanotechnology. She brings extensive international experience, notably as a Scientific Project Officer at the European Commission’s Joint Research Center in Belgium, where she contributed to biosafety and GMO policy development. Dr. Seyran has a strong research portfolio with over 15 publications in high-impact journals, focusing on recombinant protein expression, disease biomarkers, antifungal targets, and nanoparticle-based therapeutic and industrial applications. Her work has earned her prestigious fellowships from institutions such as the United Nations, FAO, and NSF. Notably, she holds a 2023 Turkish patent for a nanomaterial-based COVID-19 treatment formulation. A dedicated educator with two decades of teaching experience in the U.S. and Turkey, Dr. Seyran exemplifies academic excellence, innovation, and interdisciplinary research leadership.

Professional Profile 

🎓 Education of Dr. Esra Seyran

Dr. Esra Seyran has pursued a rich and multidisciplinary academic path across prestigious institutions in the USA, Italy, and Turkey. She earned her Ph.D. in Biochemistry and Molecular Biology (2006–2011) from the University of Arkansas, where her dissertation focused on the expression, purification, and redox-dependent disulfide bonding in human Von Willebrand Factor A domains. Prior to that, she completed her M.Sc. in Plant Science (2002–2005) at the same university, with research on temperature interactions in Puccinia striiformis isolates. In 2000–2001, she undertook a post-bachelor’s specialization in Plant-Microbe Interactions at the Instituto Agronomico Mediterraneo di Bari in Italy, supported by an Italian Foreign Ministry Fellowship. Her academic foundation was laid with a B.Sc. in Biochemistry from Ege University, Izmir, Turkey (1993–1999). This diverse and international educational background has empowered her to work at the intersection of molecular biology, plant pathology, and biochemical research.

💼 Professional Experience of Dr. Esra Seyran

Dr. Esra Seyran has amassed a diverse and impactful professional career spanning academia, international research institutions, and policy advisory roles. She currently serves as an Assistant Professor at Cumhuriyet University’s Department of Molecular Biology and Genetics in Turkey, where she has been a faculty member since 2014. Prior to her current role, she worked as an Instructor at the same university from 2014 to 2021, teaching advanced courses in biochemistry, toxicology, and genetics. Between 2011 and 2013, Dr. Seyran held the position of Scientific Project Officer at the European Commission’s Joint Research Center (DG-JRC) in Geel, Belgium, where she provided policy advice on biosafety, GMOs, and pesticide regulation, while contributing to capacity-building efforts in alignment with EU standards. Her early career includes roles as a Teaching Assistant in the Department of Chemistry and Biochemistry (2006–2011) and a Research Assistant in Plant Pathology (2002–2005) at the University of Arkansas, where she also engaged in undergraduate instruction across a range of chemistry and biochemistry subjects. This blend of research, teaching, and international policy work reflects Dr. Seyran’s multifaceted expertise and professional versatility.

🔬 Research Interests of Dr. Esra Seyran

Dr. Esra Seyran’s research interests lie at the intersection of biochemistry, molecular biology, plant pathology, and nanotechnology, with a strong emphasis on translational and interdisciplinary science. Her work focuses on recombinant protein expression and purification, particularly the structural and functional analysis of Von Willebrand Factor domains, which has implications in cardiovascular and hematological disorders. She is also deeply involved in studying biochemical markers for metabolic and macrovascular diseases, such as diabetes. Dr. Seyran explores site-specific protein modifications, such as glycation and acetylation, and their impact on drug-protein interactions. Additionally, she has contributed to the development of nanoparticle-based materials for both therapeutic applications (e.g., COVID-19 treatment formulations) and industrial innovations, including corrosion inhibitors. Her early research in plant-microbe interactions and fungal pathogens also reflects a continued interest in agricultural biotechnology and host-pathogen dynamics. With this broad yet integrated focus, Dr. Seyran aims to bridge fundamental biochemical research with real-world applications in medicine, agriculture, and material science.

🏅 Awards and Honors of Dr. Esra Seyran

Dr. Esra Seyran has been recognized with numerous prestigious awards and fellowships throughout her academic and professional journey, reflecting her excellence in research, innovation, and international collaboration. In 2016, she was honored with the United Nations Arturo Falaschi Research Fellowship, acknowledging her contributions to molecular biology. She also received the FAO Training Fellowship in 2012 for her work on obsolete pesticide management. During her doctoral studies, she was awarded the Distinguished Doctoral Fellowship by the University of Arkansas Department of Chemistry in 2007, and the same year secured a National Science Foundation Scholarship for advanced training in microbial genetics at the Craig Venter Institute. Earlier accolades include the Asia Rice Foundation Research Award in 2006, and the Graduate School Travel Award from the University of Arkansas in 2004. Dr. Seyran also benefited from the Italian Foreign Ministry Cultural Exchange Scholarship (2000–2001), which supported her studies in plant-microbe interactions in Italy. These honors highlight her outstanding academic potential, international impact, and dedication to scientific advancement.

🏁 Conclusion

Dr. Esra Seyran presents a highly competitive and well-rounded profile suitable for the Best Researcher Award. Her work bridges cutting-edge biochemistry, biomedical innovation, agricultural science, and public policy, making her a rare multidisciplinary contributor. Her global research footprint, commitment to teaching, technical competencies, and novel contributions (e.g., patent) strongly support her eligibility and worthiness for recognition.

📚 Publications Top Noted

  1. Title: Aggressiveness of Puccinia striiformis f. sp. tritici isolates in the south-central United States
    Authors: EA Milus, E Seyran, R McNew
    Year: 2006
    Cited by: 190
  2. Title: New breeding techniques and their possible regulation
    Authors: E Seyran, W Craig
    Year: 2018
    Cited by: 23
  3. Title: Examination of the rice blast pathogen population diversity in Arkansas, USA – Stable or unstable?
    Authors: JC Correll, EJ Boza, E Seyran, RD Cartwright, Y Jia, FN Lee
    Year: 2009
    Cited by: 20
  4. Title: A preliminary characterization of the rice blast fungus on ‘Banks’ rice
    Authors: FN Lee, RD Cartwright, Y Jia, JC Correll, KAK Moldenhauer, JW Gibbons, V Boyett, E Zhou, E Boza, E Seyran
    Year: 2004
    Cited by: 20
  5. Title: New Races of Puccinia striiformis f. sp. tritici More Aggressive Than Older Races
    Authors: ESE Milus
    Year: 2005
    Cited by: 9
  6. Title: Aggressiveness of Puccinia striiformis f. sp. tritici
    Authors: EA Milus, E Seyran, R McNew
    Year: 2006
    Cited by: 3
  7. Title: Fungal homoserine transacetylase: a potential antifungal target
    Authors: E Seyran
    Year: 2021
    Cited by: 2
  8. Title: Isolate by temperature interaction for aggressiveness among isolates of Puccinia striiformis f. sp. tritici
    Authors: E Seyran, EA Milus
    Year: 2004
    Cited by: 2
  9. Title: The effects of aspirin acetylation of human serum albumin on its interactions with methotrexate
    Authors: Esra Seyran, Serap Cetinkaya
    Year: 2025
    Cited by: 1
  10. Title: Nanoparticle-Based Corrosion Inhibitors
    Authors: E Seyran, G Tüzün, S Çetinkaya, B Tüzün
    Year: 2024
    Cited by: 1

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Tawanda Chivese, University of Washington Tacoma, United States

Assist. Prof. Dr. Tawanda Chivese is an accomplished epidemiologist specializing in clinical epidemiology. With a Ph.D. in Medicine from the University of Cape Town, and an MSc (cum laude) in Clinical Epidemiology from Stellenbosch University, Dr. Chivese has a strong foundation in advanced epidemiological methods, biostatistics, and global health. He is currently an Assistant Professor of Epidemiology at the University of Washington Tacoma, and an Extraordinary Senior Lecturer at Stellenbosch University. Over his career, Dr. Chivese has led impactful international research on diabetes, gestational diabetes, cardiometabolic diseases, and mental health outcomes. His work has been published in high-impact peer-reviewed journals, and he actively contributes as a journal reviewer and editorial board member. Dr. Chivese’s commitment to academic excellence, mentorship, and research collaboration marks him as a distinguished researcher with significant contributions to global public health.

Publication Profile

Orcid

Education

Dr. Tawanda Chivese holds a Ph.D. in Medicine (2021) from the University of Cape Town, where he investigated the long-term effects of hyperglycemia in pregnancy on offspring obesity and cardiovascular risk. He earned his MSc Clinical Epidemiology (cum laude, 2014) from Stellenbosch University, completing advanced coursework in epidemiology, biostatistics, and systematic reviews. His Master’s research focused on cigarette smoking and Crohn’s Disease phenotypes. Earlier, he completed a Bachelor of Science (Honours) in Nursing Science (2006) from the University of Zimbabwe, developing a strong clinical foundation. He has supplemented his formal education with specialized training in systematic reviews, digital skills, blended learning, biomedical ethics, and diagnostic test accuracy through global institutions like the University of Birmingham and the University of Oxford. Dr. Chivese’s comprehensive education underpins his expertise in clinical epidemiology and global health research.

Experience

Dr. Chivese is currently an Assistant Professor (tenure-track) at the University of Washington Tacoma (2024-present), leading epidemiology and public health teaching, collaborative research on gestational diabetes, and supervising student research. Previously, he served as Assistant Professor at Qatar University (2019-2024), where he coordinated key courses, redesigned epidemiology curricula, and mentored over 100 student researchers, many winning top awards. He fostered collaborations with the Qatar Ministry of Public Health and Qatar Biobank. Concurrently, Dr. Chivese has held honorary positions at Stellenbosch University and the South African Medical Research Council since 2016. His experience combines academic leadership, innovative teaching, curriculum development, large-scale collaborative research, and scholarly publication. His global impact is evidenced by partnerships across Africa, the Middle East, and the U.S., positioning him as a leading figure in global clinical epidemiology.

Awards and Honors

Dr. Tawanda Chivese’s dedication to excellence has earned him multiple accolades. He received consistent teaching excellence awards during his tenure at Qatar University and awards for supervising the best undergraduate research projects. His leadership contributions to the Public Health Association of South Africa, serving on the executive board and as Vice Chairperson for a special interest group, underline his influence in public health leadership. His scholarly work has been recognized with prestigious grants, including funding from Qatar Foundation, Welcome Trust, and SAMRC/Newton Fund. In addition, he has been selected as an editorial board member for BMC Public Health and frequently reviews for top-tier journals like The Lancet and PLOS Medicine. These honors reflect his outstanding achievements in research, teaching, mentorship, and service to the academic and public health communities.

Research Focus

Dr. Chivese’s research primarily focuses on the intersection of metabolic and mental health diseases, particularly diabetes, cardiovascular risks, and cognitive outcomes post-gestational diabetes. He specializes in clinical epidemiology, meta-analysis, and diagnostic accuracy studies. His recent projects include investigating the developmental origins of autism spectrum disorders, the role of poor glycemic control in cognitive dysfunction, and refining meta-analysis methods for improved evidence synthesis. He also leads collaborative studies on lifestyle interventions to prevent cardiometabolic diseases in high-risk populations. His work aims to uncover critical determinants of chronic disease progression and provide actionable public health interventions. Dr. Chivese’s research approach is interdisciplinary, combining clinical insight, advanced statistical methods, and global collaboration to address complex health challenges in both low- and high-income settings.

Publication Top Notes

Prevalence of unintended pregnancy in the MENA region: a systematic review and meta-analysis

Infoveillance of COVID-19 Infections in Dentistry Using Platform X: Descriptive Study

Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis

Cross-cultural adaptation: South African Gestational Diabetes Mellitus Knowledge Questionnaire

Prevalence and factors associated with falls in older adults in a Middle Eastern population: a retrospective cross-sectional study

Estimates of the prevalence of male circumcision in sub-Saharan Africa from 2010–2023—A systematic review and meta-analysis

Integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomised controlled trial protocol

giuseppina malcangi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

giuseppina malcangi | Medicine and Health Sciences | Best Researcher Award

Dr giuseppina malcangi, University of Bari “Aldo Moro, Italy

Dr. Giuseppina Malcangi is a distinguished researcher in dentistry, specializing in oral surgery, implantology, and orthodontics. She has made significant contributions to regenerative dentistry, nanotechnology applications, and platelet-based therapies. With 128+ indexed publications (h-index: 29, 2397 citations), she has earned global recognition. Her groundbreaking work on herbal medicine for oral health, platelet concentrates in facial rejuvenation, and cytokine interactions in orthodontics highlights her innovative approach. In December 2023, she secured the ASN (Abilitazione Scientifica Nazionale) for Associate Professor, affirming her excellence. Her dedication to advancing dentistry through evidence-based research makes her a strong candidate for the Best Researcher Award.

Publication Profile

Orcid

Education & Specialization

Dr. Giuseppina Malcangi earned her Degree in Dentistry and Dental Prosthetics from the University of Bari, Italy, in 1989. She pursued advanced education with 1st and 2nd level International Master’s in Advanced Oral Surgery and Dental Implantology. Further specializing in Orthodontics, she completed her training at the Interdisciplinary Department of Medicine (D.I.M.), Bari University “Aldo Moro.” Her academic foundation integrates surgical expertise, orthodontic precision, and implantology, ensuring a holistic approach to dental treatments. Her dedication to lifelong learning and specialization in innovative techniques has solidified her reputation as a leading expert in dental research and clinical applications. 🎓🦷🔬

Awards & Honors

Dr. Giuseppina Malcangi earned the ASN Associate Professor Qualification in 2023, a testament to her academic excellence. 🏆 A recognized innovator in dentistry, she holds an international patent for groundbreaking research. 🔬📜 With an impressive portfolio of 128+ indexed journal papers (h-index: 29), four book chapters, and over 50 national journal articles, she has made a lasting impact on dental science. 📚✍️ Her research is widely referenced, accumulating 2,397+ citations as of March 2025. 🔍 As a CLOPD Subject Matter Expert, she is highly regarded for her expertise in oral health sciences. 🏛️ Her commitment to advancing dentistry is evident in her extensive contributions, including high-impact publications, patents, and academic leadership. Through innovation and scholarly excellence, she continues to push the boundaries of dental science, influencing the next generation of researchers and practitioners. 🏅🔬📖

Research Focus

Dr. Malcangi’s research delves into cutting-edge advancements in dentistry, integrating modern technology with traditional practices to enhance patient outcomes. 💡📖🦷 Her work in regenerative dentistry explores the use of stem cells for oral tissue regeneration, offering innovative solutions for dental repair. 🧬🦷 She also pioneers nanotechnology applications, improving the durability and functionality of dental materials. 🏗️🔬 Additionally, she investigates the role of herbal medicine in oral health, developing natural anti-inflammatory treatments for gum diseases. 🌿🩺 Her studies on platelet concentrates and growth factors focus on their applications in facial rejuvenation, contributing to aesthetic and therapeutic advancements. 💉💆‍♀️ Furthermore, her research on cytokine interactions in orthodontics enhances treatment efficiency, optimizing patient care. 🔄😬 By bridging traditional methods with state-of-the-art innovations, Dr. Malcangi continues to shape the future of dentistry, driving progress in both research and clinical practice. 🏅🔬📖

Publication Top Notes

Effectiveness of Herbal Medicines with Anti-Inflammatory, Antimicrobial, and Antioxidant Properties in Improving Oral Health and Treating Gingivitis and Periodontitis: A Systematic Review

The Role of Platelet Concentrates and Growth Factors in Facial Rejuvenation: A Systematic Review with Case Series

The Diagnosis and Management of Infraoccluded Deciduous Molars: A Systematic Review

Stem Cells: Present Understanding and Prospects for Regenerative Dentistry

Nanotechnology and Its Application in Dentistry: A Systematic Review of Recent Advances and Innovations

The Effectiveness of Curcumin in Treating Oral Mucositis Related to Radiation and Chemotherapy: A Systematic Review

The Use of Platelet-Rich Fibrin (PRF) in the Management of Dry Socket: A Systematic Review

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Published on by Research Hypothesis

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year 🏆 (Miller School of Medicine, 2015), the Outstanding Care Award 🏅 (Sarcoma Alliance, 2012), and the Leadership in Clinical Research 🎖️ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER

sang ho choi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

sang ho choi | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr sang ho choi, Kwangwoon University, South Korea

Assist. Prof. Dr. Sang Ho Choi is an expert in biomedical engineering and artificial intelligence, currently serving as an Assistant Professor at Kwangwoon University, Seoul, Korea 🇰🇷. He leads the Healthcare & AI Lab 🧠🤖. Previously, he worked as a Staff Engineer at Samsung Research 📱. Dr. Choi earned his Ph.D. in Biomedical Engineering from Seoul National University 🎓, focusing on sleep monitoring using deep neural networks 😴🔍. His research interests include biomedical signal processing, AI for healthcare, and IoT systems 🌐. He has published extensively on sleep engineering, neural networks, and health monitoring technologies 📊📚.

Publication Profile

Orcid

Education

Assist. Prof. Dr. Sang Ho Choi is a skilled academic with a Ph.D. in Biomedical Engineering from Seoul National University (2014–2020), where he specialized in unconstrained sleep monitoring and modulation using deep neural networks and closed-loop stimulation. He conducted his research under the guidance of Prof. Kwang Suk Park. Prior to this, he earned a B.S. in Bio-mechatronic Engineering, with a double major in Electronic and Electrical Engineering, from Sungkyunkwan University (2009–2014). He was mentored by Prof. Chang Hyun Choi and Prof. Jitae Shin. His work integrates bioengineering and innovative neural network technologies. 🧠💻🎓

Experience

The research initiatives include groundbreaking work in neuro-chip design and neuro-computing platforms, simulating the human nervous system, funded by the Ministry of Science and ICT (MSIT) Korea (Jul 2022 – Dec 2029) as Co-PI. Another project focuses on intelligent biomedical wireless power transfer, under the National Research Foundation of Korea (NRF) (Mar 2022 – Feb 2024), also as Co-PI. Additionally, the development of AI-based vital signal and sleep monitoring technology using UWB radar is being led as PI (Jul 2021 – Feb 2023) by the NRF. These innovative efforts aim to revolutionize healthcare technology. 🧠💡📡🤖

Research Interest

Assist. Prof. Dr. Sang Ho Choi specializes in biomedical signal processing and analysis, with a strong focus on Artificial Intelligence (AI) applications for biomedical engineering and deep learning. His research spans areas like sleep engineering, healthcare systems, and the integration of Internet of Things (IoT) systems to enhance healthcare outcomes. By leveraging advanced AI techniques, Dr. Choi explores innovative solutions for improving diagnostics, treatment processes, and patient care efficiency. His work aims to merge technology with healthcare, contributing significantly to the future of smart, data-driven medical systems. 🧠💡🩺🤖💻

Ongoing Projects

Assist. Prof. Dr. Sang Ho Choi is a Co-PI on significant national projects funded by Korea’s MSIT and NRF, leading innovative research in the fields of neuro-chip design and AI-driven health monitoring technologies. His work is shaping the future of healthcare by integrating advanced neurotechnology with artificial intelligence. With a passion for cutting-edge scientific advancements, Dr. Choi’s contributions are paving the way for transformative breakthroughs in medical devices and digital health. His dedication to improving healthcare through technological innovation continues to inspire and drive progress in the industry. 🧠💡🤖💊🔬

Research Focus

Assist. Prof. Dr. Sang Ho Choi’s research primarily focuses on biomedical signal processing and health monitoring using advanced sensor technologies. His work includes exploring wearable devices for sleep monitoring, studying the functional connectivity of the amygdala in chronic insomnia patients, and utilizing spiking neural networks for analyzing biomedical signals. He also investigates real-time detection systems, like apnea-hypopnea event detection using radar sensors, and continues to push the boundaries of sensor-based health technologies. His contributions extend to neuroengineering and biomedical engineering, aiming to enhance the accuracy and efficiency of health monitoring systems. 🧠📡💡💤👩‍⚕️

Publication Top Notes

Biomedical Signal Processing and Health Monitoring Based on Sensors

Spiking neural networks for biomedical signal analysis

Amygdala resting-state functional connectivity alterations in patients with chronic insomnia disorder: correlation with electroencephalography beta power during sleep

Technologies for sleep monitoring at home: wearables and nearables

Hybrid CNN-LSTM Network for Real-Time Apnea-Hypopnea Event Detection Based on IR-UWB Radar

Long Short-Term Memory Networks for Unconstrained Sleep Stage Classification Using Polyvinylidene Fluoride Film Sensor

Sleep-Dependent Directional Coupling of Cardiorespiratory System in Patients With Obstructive Sleep Apnea